2024-03-28T23:17:21Z
https://niigata-u.repo.nii.ac.jp/oai
oai:niigata-u.repo.nii.ac.jp:00011310
2022-12-15T03:44:43Z
453:456
471:537:538:993
肝細胞癌のCT,MRI診断
肝細胞癌のCT,MRI診断
Hepatocellular carcinoma: diagnosis with CT and MRI
加村, 毅
本文データは学協会の許諾に基づきCiNiiから複製したものである
hepatocellular carcinoma
X-ray computed tomography (CT)
magnetic resonance imaging (MRI)
The current frontiers of diagnostic imagings on hepatocellular carcinoma (HCC) are as follows: first, the detection of well differentiated HCC (w-HCC), and second, the detection and confirmation of moderately or poorly differentiated HCC (mp-HCC) less than 10 mm in diameter. HCC nodules developed first as w-HCC, and then they become mp-HCC (de-differentiation). The w-HCC shows more favorite prognosis than and -HCC. The detection rates of w-HCC histologically proved with hepatic resection and percutaneous ultrasonography-guided biopsy are 63 % (17/29) with X-ray computed tomography (CT), and 68 % (18/29) with magnetic resonance imaging (MRI). However, we may miss a lot of w -HCCs, because most of the HCC nodules are found as mp -HCC. Most of the mp -HCCs larger than 1cm in diameter are detected and confirmed with CT and MRI. The smaller mp -HCC nodules are difficult to detect and confirm, and CT with intra -arterial administration of contrast materials may show more nodules. Intrahepatic arterio - portal shunts and some of hyperplastic hepatocellular nodules (mainly developed in Budd - Chiari syndrome and alcoholic liver cirrhosis) mimic mp -HCC, and to differentiate the latter, T2 - weighted images of MRI may be useful.
新潟医学会
2008-03
jpn
departmental bulletin paper
http://hdl.handle.net/10191/19601
https://niigata-u.repo.nii.ac.jp/records/11310
AN00182415
00290440
新潟医学会雑誌
新潟医学会雑誌
122
3
119
127
https://niigata-u.repo.nii.ac.jp/record/11310/files/110007146299.pdf
application/pdf
2.9 MB
2019-08-06